Northern Trust Company of Connecticut’s ResMed RMD Stock Holding History

Northern Trust Company of Connecticut’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$2.89M	Sell	61,310 -800	-1%	-$40.5K	0.02%	916
2013 Q3	$3.28M	Sell	62,110 -1,850	-3%	-$89.7K	0.02%	856
2013 Q2	$2.89M	Buy	+63,960	New	+$3.03M	0.02%	881

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Northern Trust Company of Connecticut's RMD Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its ResMed (RMD) stake by 1.3% in Q4 2013, selling an estimated $40.5K and leaving 61,310 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #916.

Northern Trust Company of Connecticut first reported a position in RMD in Q2 2013 and has held it in 3 quarters since. The position peaked at $3.28M in Q3 2013. 329 funds tracked by Wall St. Rank hold RMD as of Q4 2013.

Northern Trust Company of Connecticut held 61,310 shares of ResMed worth $2.89M as of Q4 2013.
Northern Trust Company of Connecticut sold 800 ResMed shares in Q4 2013, an estimated $40.5K.
ResMed made up 0.02% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #916 holding.
Northern Trust Company of Connecticut first reported a position in ResMed in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's ResMed position peaked at $3.28M in Q3 2013.
329 funds tracked by Wall St. Rank held ResMed as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.